Restart Life Sciences Corp.

Restart Life Sciences Corp.

NMLSF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$3.22M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Restart Life Sciences Corp.Restart Life Sciences Corp.-1.6--119%-0.3
$0.00

Current Fair Value

99.5% downside

Overvalued by 99.5% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$3.22 Million
Enterprise Value$2.93 Million
Earnings per Share$0
Beta-0.8
Outstanding Shares50,835,341

Return

Return on Equity-118.50%ROE
Return on Assets-82.46%
Return on Invested Capital-111.18%

Valuation & Multiples

P/E Ratio-1.59P/E Ratio
PEG0.49PEG
Price to Sales-Price to Sales
Price to Book Ratio-Price to Book Ratio
Enterprise Value to Revenue8.85
Enterprise Value to EBIT-1.98
Enterprise Value to Net Income-2
Total Debt to Enterprise0.12
Debt to Equity0.26Debt to Equity

Revenue Sources

No data

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Restart Life Sciences Corp.

3 employees
CEO: Steve Loutskou

Operating internationally through its various subsidiaries, Restart Life Sciences Corp. functions as a biotechnology firm. Its core endeavors include the creation of natural therapeutic remedies tailored for individuals with autism spect...